Travere Therapeutics (TVTX) Net Margin (2013 - 2026)
Travere Therapeutics (TVTX) recorded Net Margin of -23.31% in Q3 2026, down 38.90 percentage points from 15.59% a year earlier and down 2.79 percentage points from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Net Margin (2013 - 2026) Analysis & Trends
On a TTM basis, Travere Therapeutics' Net Margin came in at -18.66% as of Sep 30, 2026, up 1.65 percentage points year-over-year; for FY2025, it was -5.21%, up 132.69 percentage points from FY2024.
- Annual Net Margin has a five-year change of +80.23 percentage points (FY2020 to FY2025).
- Across earlier years, Net Margin came in at -137.90% in FY2024 (-61.20 pp), -76.70% in FY2023 (+177.71 pp) and -254.41% in FY2022.
- Quarterly Net Margin has ranged from -429.78% in Q4 2021 to 406.35% in Q3 2023 over the past five years.
- On a year-over-year basis, Net Margin rose in six of the last eight quarters, with an average year-over-year change of +84.42 percentage points.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 654.46 percentage points in Q3 2023, against a drop of 493.49 percentage points in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at -20.52% (Q2 2026), -29.17% (Q1 2026) and 2.10% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 20.69% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 19.55% |
| 10 | Travere Therapeutics | 4.97 Bn | 4.56 Bn | 221.70 Mn | -23.31% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -23.31% |
| Jun 30, 2026 | -20.52% |
| Mar 31, 2026 | -29.17% |
| Dec 31, 2025 | 2.10% |
| Sep 30, 2025 | 15.59% |
| Jun 30, 2025 | -11.14% |
| Mar 31, 2025 | -50.44% |
| Dec 31, 2024 | -80.58% |
| Sep 30, 2024 | -87.14% |
| Jun 30, 2024 | -130.11% |
| Mar 31, 2024 | -328.86% |
| Dec 31, 2023 | -200.12% |
| Sep 30, 2023 | 406.35% |
| Jun 30, 2023 | -265.96% |
| Mar 31, 2023 | -279.50% |
| Dec 31, 2022 | -224.35% |
| Sep 30, 2022 | -248.11% |
| Jun 30, 2022 | -234.10% |
| Mar 31, 2022 | -324.50% |
| Dec 31, 2021 | -429.78% |
API Access
Travere Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();